Estimating market size of secondary care diagnostic test in India

While the Indian medical equipment industry is struggling to grow and reduce our dependency on imports, China, a relatively newcomer in the global medical equipment market since the start of this century, has started conquering the global med-tech market dominated by the US and European companies.

The Middle East’s MedTech and Diagnostics sector is undergoing a dynamic transformation, fueled by rapid technological advancements and strategic healthcare investments. Garima Malhotra, Associate Partner at Praxis, outlines why the burgeoning industry is poised for significant growth, driven by a convergence of regional and global trends.

Highlighting the need to increased spending on healthcare, Garima Malhotra, Associate Partner, Healthcare and Lifesciences at Praxis Global Alliance, noted, “While last year’s budget saw a significant increase in healthcare spending, the sector is hoping for continued momentum towards the National Health Policy’s ambitious goal of allocating 2.5 per cent of GDP to healthcare. This year, the focus is expected to shift beyond mere allocation increases to strategic investments that can revolutioniz

The UAE healthcare sector is poised for remarkable growth, fueled by market expansion and rapid technological advancements. The UAE healthcare ecosystem in FY24 is ~US$ 34B and is expected to grow at a CAGR of ~8% over the next five years. This report analyzes the current state of the UAE healthcare ecosystem and highlights the transformative potential of emerging technological disruptions.

India’s healthcare sector faces a significant coverage gap, with over 70% of middle-income earners lacking health insurance, according to Praxis Global Alliance’s report.

Praxis Global Alliance has released a comprehensive report titled “Transforming UAE Healthcare Through Technology”, during the UAE Healthcare Leaders' Summit and Awards 2024 in Abu Dhabi on October 24th, 2024.

Equitable access to healthcare needs to be built on pillars of knowledge exchange, funding, infrastructure and technology

The Indian pathology market has emerged as a critical component of the country's healthcare ecosystem, driven by the increasing prevalence of chronic diseases, infections, and lifestyle-related health problems. As the demand for precise and prompt diagnosis rises, the importance of pathology services has never been more pronounced. Let's delve into the market landscape, segmentation, global and Indian test prices, types of tests, and pathology equipment base, painting a comprehensive picture of

Aryaman Tandon, Managing Partner-Healthcare, Praxis Global Alliance talks about the key trends that are poised to shape the trajectory of the diagnostic industry

The Indian diagnostics industry is projected to reach $25 billion by FY28, up from $13 billion in FY23, backed by attractive margins and growth potential.

There are around 2.8 million hospital beds in the country, including both private and public, [which means] we have around 1.7 beds per 1,000 people.

Today, medical experts and professionals are relying on the diagnostic industry before suggesting a treatment. With modern-day consumers, especially in tier 1 and tier 2 cities, now being extra cautious about their health and well-being

India’s meteoric rise as a technology superpower means our developers are now directly influencing global innovation. Indian developers are deciding the future of critical industries like financial services

As investments continue to flow in the diganostic segment with pharma companies penetrating the space, according to a report released by Praxis Global Alliance, a global management consulting and advisory services firm

Wearables or IoT (Internet of Things) devices such as smartwatches, fitness trackers, ECG monitors, blood pressure monitors, biosensors, etc. are empowering people to take charge of their lives by monitoring their health constantly and keeping track of their vitals.

Today, when everything is available at the click of a button, getting online consultation or clinical examination from a doctor does not come as a surprise.

India is making progress in efforts to bolster its pharmaceutical sector and reduce the nation’s dependence on medication from China, by expanding the scale of domestic production and reducing costs – an ambitious goal that has been given greater impetus amid the pandemic

Under this acquisition agreement, Rapidx’s advanced reference laboratory set up in Flow Cytometry, Immunofluorescence, and ELISA tests will add to Orange Health’s diagnostics services now. Moreover, after this acquisition, Orange Health will now own a Central Referral lab.

Delhivery wants to lure D2C brands with the many benefits of same-day delivery. But India's largest logistics company must dig deeper and sweeten the deal for the brands to stave off the intense competition.

This fragmentation poses a challenge in terms of capability, scalability, and quality of labs, but on the other hand, it also provides an opportunity to consolidate newer business models to evolve, says the report, "Diagnostics: Unraveling the Future", brought out by Praxis Global Alliance, a management consulting and advisory firm.

India has always been a land of great entrepreneurial promise for me

Medtech distribution platform Genworks Health Pvt Ltd on Wednesday said it has raised Rs 135 crore ($17.6 million) in fresh funding from Somerset Indus Capital Partners, Morgan Stanley, through its funding arm Grand Vista, Evolvence and Wipro GE.

India’s pharmaceutical sector expects an impetus from the Union budget 2022 which will further improve its production capacity and innovation to maintain its stance as the pharmaceutical hub of the world.

For long, the healthcare industry has been focused on offering treatment after the onset of a disease or when complications arise. With technology, the industry can now hope to bridge the gaps in the areas of preventive healthcare and disease management.

The rapid increase in health digitization has both caused and been a result of government mandates and guidelines.

Union Budget 2022-23 has given healthcare a much-needed digital push. Rolling out an open platform for the National Digital Health Ecosystem, setting up of National TeleHealth Mental Scheme

The widening gap between patients requiring treatment and available facilities made the acceptance of remote patient monitoring, online delivery of medicines, telehealth, AI-powered health solutions, etc.,

New Delhi [India], January 25 (ANI/PNN): It's 2022. Yet, the fear and panic unleashed by Covid in 2020 is yet to subside.

With contribution from developers, open source is flourishing in India, but what does this explosive growth mean? What is the economic impact of a thriving developer community? Read on to find out.

The latest investment more than doubles Pristyn Care’s valuation, as the healthcare startup’s total fund tally now stands at about $175 million.

While Covid-19 exposed the dire state of India’s health care system during the first and second wave, it opened doors for many budding,

The COVID-19 pandemic wreaked havoc not only on human health but also on the global economy.

Up to 60% of healthcare facilities in India are concentrated in large cities. Health-tech firms are trying to bridge this divide by leveraging technology.

In the last one-year, online health services have witnessed an unprecedented surge in acceptance. The lockdowns and advisories cautioning the elderly, children, and people suffering from chronic diseases against visiting physical healthcare facilities, contributed to a significant number of people opting for online medical support, leading to the rise of telemedicine in India.

Lal wanted to be a fighter pilot in the navy but destiny had other plans. Today, with Lal PathLabs, he is at the forefront of a health tech revolution seventy years after his father started the company as a single private diagnostic lab in New Delhi

Cybercrimes are advancing at a rate which we can no longer afford to ignore. If everyone does their part by implementing stronger security practices, raising community awareness, educating vulnerable audiences, our interconnected world will be safer and more resilient for everyone.

The company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder Nandan Nilekani's venture fund Fundamentum, Eight Roads Ventures and Bessemer Venture Partners will make a partial exit.

Prime Minister Narendra Modi interacts with Union Health Minister Mansukh Mandaviya and Minister for Railways, Communications, Electronics, and Information Technology Ashwini Vaishnaw during the launch of Ayushman Bharat Digital Mission. The platform will be used by patients and providers to discover, book, pay and fulfil various digital health services, such as teleconsultations, across applications.

Docty is a global telehealth startup that provides doctor search and appointment services, online consultations, medicine delivery, electronic medical records, remote monitoring, and symptom pre-screening services among others — all under a single platform.

Talks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.

The pandemic has put the focus back on India’s creaky healthcare infrastructure, which has been hobbled by issues of accessibility, affordability and availability.

PharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation of around $5.6 billion, the sources added.

Indians do three doctor consultations in a year; each consultation leads to one pharma prescription, and a diagnostics test is prescribed in every 3.5 consultations where the general physicians show the highest number of consultations and associated pharma prescriptions.

Covid-19 has led to record growth in online doctor consultations in the past one year in India. India's teleconsultation market size was about $26 million in March last year, but it has grown to $163 million by March 2021 on an annualised run-rate basis.

As per estimates, the number of households using E-pharmacy services grew 2.5 times to 9 million during COVID times.

The deal with PharmEasy, India's first e-pharmacy unicorn, will give Thyrocare an opening into B2C business and its founder an investing foray into the burgeoning healthtech sector

A great pharma and medical supply chain, large population, intent among health professionals to innovate, and willingness among customers to try new solutions will ensure the sector's success.

According to an Internet and Mobile Association of India (IAMAI) and Praxis report, the Indian Healthtech industry is expected to reach USD 5 billion by 2023 at the compounded annual growth rate (CAGR) of 39 per cent.

HealthTech innovators need to look beyond the e-pharmacy and B2B solutions, as newer areas such as telemedicine, e-diagnostics, personal health, preventive healthcare are screaming for their attention.

Praxis Global Alliance, a management consulting and advisory services firm today announced that it has appointed Sumit Goel as managing partner and practice leader for its healthcare, pharmaceuticals, and life sciences practices.

The covid-19 pandemic has accelerated growth of the Indian healthtech industry, which is expected to touch $5 billion by 2023.

The Lancet Commission for Global Surgery estimates that 5,000 surgeries are required to meet the surgical burden of disease for 1,00,000 people in low and middle income countries, like India. But according to a pan-India surgery market report, in India only 1,463 surgeries happen per lakh, just 29% of the needed 5,000 per lakh.

No boost to encourage private investment in healthcare infrastructure, medical devices

India’s nationwide Covid-19 vaccination drive will kick off tomorrow, with 3 Lakh healthcare workers getting vaccinated

In an interaction with ETHealthworld, Aryaman Tandon, Practice Leader, Healthcare, Praxis Global Alliance, shares his perspective on National Digital Health Mission.

Earlier this week, the centre approved NDHM’s health data management policy, meant to set out the minimum standard in data privacy protection, for all participants in the National Digital Health Ecosystem

Today, we all are amidst an unprecedented pandemic that has an unfavourable impact on the country’s economy and its healthcare system. Due to the surge in demand for COVID-19 kits, ventilators, etc., there is a sudden increase in the load on healthcare infrastructure/workforce of the country.

Covid-19 has fuelled the pace of change in the healthcare sector, from tele-health expansion to the deployment of temporary hospitals.

COVID-19 pandemic continues to be a primary concern for the healthcare industry and workers alike. With plans and protocols around patient care, testing and treatment changing almost every fortnight, concerns around hospitals’ financial operations, revenue cycles amidst the shortage of staff and medical supplies, are becoming a cause of concern.

The shift towards online consultations spurs growth in e-health startups

COVID-19 offers a silver lining for eHealth platforms — to embrace change, join forces, and to innovate, creating real value in the healthcare ecosystem

This week on Startup Street, a bigger picture of the problems plaguing India’s startup ecosystem, what the community wants and what is being done, at a time Covid-19 stalled businesses temporarily.

India’s consumer goods giants and legacy retailers are forging unique alliances with online aggregators to tide over the logistical hurdles created by the Covid-19 pandemic.

Dr. Anuj Gupta, Former VP, Healthcare, Praxis Global Alliance speaks on understanding HealthTech in India

Healthcare has become one of India's largest sectors both in terms of revenue and employment. For the medical supplies segment particularly, Asia is projected to be the fastest-growing region owing to factors such as the rising geriatric population, increasing incidence of various diseases, growing medical tourism industry, and improving healthcare infrastructure.

A 65-year old woman in a small village in Pune had to be carried over a makeshift stretcher for about 2 hours across 8 kms to get basic primary healthcare after a snake bite.

In India, around 16 lakh patients die every year due to porr quality of care, and adverse drug reactions is one of the major causes of these deaths.

Healthcare will be a dominant theme in India over the next few decades. But with a largely self - financed healthcare system, robust top-line growth will be a challenge for several hospital chains for a while. Disease profiles are changing and becoming more chronic, and interesting models are emerging to service this demand. In addition, the thrust on insurance is also opening up a wider market.

In 2018, by introducing Ayushman Bharat - PMJAY, which ensures universal coverage for 500M Indians, the Indian Government has been anticipating support from the private sector in uplifting the country's healthcare status.

The health insurance scheme, which some feel focuses on tertiary case, has got a big funding boost in the budget, while other healthcare programs took a backseat.

When it was asked on a social media platform “What does wellness mean to you?”. Here is what the netizens had to say.